Literature DB >> 10777476

Mechanism of reaction of myeloperoxidase with nitrite.

U Burner1, P G Furtmuller, A J Kettle, W H Koppenol, C Obinger.   

Abstract

Myeloperoxidase (MPO) is a major neutrophil protein and may be involved in the nitration of tyrosine residues observed in a wide range of inflammatory diseases that involve neutrophils and macrophage activation. In order to clarify if nitrite could be a physiological substrate of myeloperoxidase, we investigated the reactions of the ferric enzyme and its redox intermediates, compound I and compound II, with nitrite under pre-steady state conditions by using sequential mixing stopped-flow analysis in the pH range 4-8. At 15 degrees C the rate of formation of the low spin MPO-nitrite complex is (2.5 +/- 0.2) x 10(4) m(-1) s(-1) at pH 7 and (2.2 +/- 0.7) x 10(6) m(-1) s(-1) at pH 5. The dissociation constant of nitrite bound to the native enzyme is 2.3 +/- 0.1 mm at pH 7 and 31.3 +/- 0.5 micrometer at pH 5. Nitrite is oxidized by two one-electron steps in the MPO peroxidase cycle. The second-order rate constant of reduction of compound I to compound II at 15 degrees C is (2.0 +/- 0.2) x 10(6) m(-1) s(-1) at pH 7 and (1.1 +/- 0.2) x 10(7) m(-1) s(-1) at pH 5. The rate constant of reduction of compound II to the ferric native enzyme at 15 degrees C is (5.5 +/- 0.1) x 10(2) m(-1) s(-1) at pH 7 and (8.9 +/- 1.6) x 10(4) m(-1) s(-1) at pH 5. pH dependence studies suggest that both complex formation between the ferric enzyme and nitrite and nitrite oxidation by compounds I and II are controlled by a residue with a pK(a) of (4.3 +/- 0.3). Protonation of this group (which is most likely the distal histidine) is necessary for optimum nitrite binding and oxidation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777476     DOI: 10.1074/jbc.M000181200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Airway peroxidases catalyze nitration of the {beta}2-agonist salbutamol and decrease its pharmacological activity.

Authors:  Krzysztof J Reszka; Larry Sallans; Stephen Macha; Kari Brown; Dennis W McGraw; Melinda Butsch Kovacic; Bradley E Britigan
Journal:  J Pharmacol Exp Ther       Date:  2010-10-25       Impact factor: 4.030

2.  Plasma concentrations of a type II collagen-derived peptide and its nitrated form in growing Ardenner sound horses and in horses suffering from juvenile digital degenerative osteoarthropathy.

Authors:  J-Ph Lejeune; D Serteyn; M Gangl; N Schneider; G Deby-Dupont; M Deberg; Y Henrotin
Journal:  Vet Res Commun       Date:  2007-01-24       Impact factor: 2.459

3.  The effect of neighboring methionine residue on tyrosine nitration and oxidation in peptides treated with MPO, H2O2, and NO2(-) or peroxynitrite and bicarbonate: role of intramolecular electron transfer mechanism?

Authors:  Hao Zhang; Jacek Zielonka; Adam Sikora; Joy Joseph; Yingkai Xu; B Kalyanaraman
Journal:  Arch Biochem Biophys       Date:  2008-11-24       Impact factor: 4.013

4.  Do β-cells generate peroxynitrite in response to cytokine treatment?

Authors:  Katarzyna A Broniowska; Clayton E Mathews; John A Corbett
Journal:  J Biol Chem       Date:  2013-11-05       Impact factor: 5.157

Review 5.  Thiol chemistry in peroxidase catalysis and redox signaling.

Authors:  Alberto Bindoli; Jon M Fukuto; Henry Jay Forman
Journal:  Antioxid Redox Signal       Date:  2008-09       Impact factor: 8.401

Review 6.  Biological nitric oxide signalling: chemistry and terminology.

Authors:  Tassiele A Heinrich; Roberto S da Silva; Katrina M Miranda; Christopher H Switzer; David A Wink; Jon M Fukuto
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

7.  Kinetic analysis of intracellular concentrations of reactive nitrogen species.

Authors:  Chang Hoon Lim; Peter C Dedon; William M Deen
Journal:  Chem Res Toxicol       Date:  2008-11       Impact factor: 3.739

Review 8.  The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.

Authors:  Garry G Graham; Michael J Davies; Richard O Day; Anthoulla Mohamudally; Kieran F Scott
Journal:  Inflammopharmacology       Date:  2013-05-30       Impact factor: 4.473

9.  Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

Authors:  Lemin Zheng; Benedicta Nukuna; Marie-Luise Brennan; Mingjiang Sun; Marlene Goormastic; Megan Settle; Dave Schmitt; Xiaoming Fu; Leonor Thomson; Paul L Fox; Harry Ischiropoulos; Jonathan D Smith; Michael Kinter; Stanley L Hazen
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 10.  Oxidative stress and the HIV-infected brain proteome.

Authors:  Lerna Uzasci; Avindra Nath; Robert Cotter
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.